珠江啤酒(002461.SZ):廣州國發減持股份再次達到1%
格隆匯6月9日丨珠江啤酒(002461.SZ)公佈,公司於2021年6月9日接到《廣州國發關於權益變動1%的吿知函》,函件稱:自2020年11月25日通過公司披露了《關於控股股東的一致行動人減持計劃數量過半暨減持股份達1%的公吿》至2021年6月8日,廣州國發減持股份已再次達到1%。
廣州國發於2020年11月24日-2021年6月8日通過集中競價方式累計減持公司股份2373.95萬股,佔公司總股本的1.072571%。控股股東及一致行動人當前持有公司股份約11.99億股,佔公司總股本的54.18%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.